84 related articles for article (PubMed ID: 24363202)
1. Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.
Bai C; Tang S; Bai C; Chen X
Amino Acids; 2014 Apr; 46(4):841-52. PubMed ID: 24363202
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.
Tang S; Bao H; Zhang Y; Yao J; Yang P; Chen X
PLoS One; 2013; 8(3):e55268. PubMed ID: 23472066
[TBL] [Abstract][Full Text] [Related]
3. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.
Tang S; Bai C; Yang P; Chen X
J Proteome Res; 2013 Jun; 12(6):2511-24. PubMed ID: 23590642
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
Ko BS; Jan YJ; Chang TC; Liang SM; Chen SC; Liu TA; Wu YM; Wang J; Liou JY
Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
Ko BS; Chang TC; Hsu C; Chen YC; Shen TL; Chen SC; Wang J; Wu KK; Jan YJ; Liou JY
Histopathology; 2011 Apr; 58(5):705-11. PubMed ID: 21401702
[TBL] [Abstract][Full Text] [Related]
7. Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.
Yang X; Zou P; Yao J; Yun D; Bao H; Du R; Long J; Chen X
J Proteome Res; 2010 Mar; 9(3):1402-15. PubMed ID: 20000738
[TBL] [Abstract][Full Text] [Related]
8. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
10. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation.
Liang S; Xu Y; Shen G; Liu Q; Zhao X; Xu Z; Xie X; Gong F; Li R; Wei Y
Electrophoresis; 2009 Dec; 30(23):4152-62. PubMed ID: 19960480
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
[TBL] [Abstract][Full Text] [Related]
12. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induced by 1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic analysis.
Fu WM; Zhang JF; Wang H; Tan HS; Wang WM; Chen SC; Zhu X; Chan TM; Tse CM; Leung KS; Lu G; Xu HX; Kung HF
Apoptosis; 2012 Aug; 17(8):842-51. PubMed ID: 22610480
[TBL] [Abstract][Full Text] [Related]
14. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P
Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
[TBL] [Abstract][Full Text] [Related]
17. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin.
Huang JF; Guo YJ; Zhao CX; Yuan SX; Wang Y; Tang GN; Zhou WP; Sun SH
Hepatology; 2013 May; 57(5):1882-92. PubMed ID: 23239537
[TBL] [Abstract][Full Text] [Related]
19. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
